Altimmune, Inc. — Director's Dealing 2020

May 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2020-05-11

Reporting Person: Jorkasky Diane (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-11	Stock Options (option to buy)	$3.15	A	40000	Acquired	2030-05-11	Common Stock, par value $0.0001 (40000)	Direct

Footnotes

F1: The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments, subject to the reporting person's continued service through the applicable vesting date.